Biotech companies Cytune Pharma and SOTIO have recently declared that they have initiated SO-C101 dosing of cancer patients. The phase I/Ib clinical trial will assess the preliminary efficacy and safe....

Visitors can get some tech support or test the Microsoft games and software at the outlet Microsoft has recently unveiled a three-story store on Regent Street, the heart of London, spanning over an....

ABB, a leader in automation technology, is partnering with Enel Green Power, an Italian renewable energy corporation, to lower maintenance costs, transform performance, reliability & energy effici....

FORM, a Canada based sports technology company recently announced the launch of FORM Swim Goggles which are a pair of augmented reality enabled swim goggles that can help competitive swimmers view th....

The sale highlights the company’s commitment towards obtaining value from non-core assets Encana Corporation has recently announced that Newfield Exploration Mid-Continent Inc., its wholly owned ....

The expected outcome of the PRIMROSE1 clinical trial is to establish a significant reduction in menstrual bleeding assessed by alkaline hematin method, the results of which is expected in 1H 2020. ....

First out of eleven similar patents submitted cover different drug combinations. Ares Genetics GmbH – a subsidiary of molecular diagnostic developer Curetis N.V. has reportedly been granted a pat....

FDA approved the treatment under its accelerated approval program Reports confirm that the U.S. Food and Drug Administration (FDA) has granted approval to Xpovio tablets in combination with the Dex....

21 subjects with mCRPC were enrolled into one of six cohorts of ascending TRC253 doses. The clinical stage biopharmaceutical firm TRACON Pharmaceuticals has reportedly announced an update on its TR....